ESR1 and breast carcinoma: The effects of different concentrations (0, 6, 12.5, 25, 50, or 100 μM) of emodin and aloe-emodin on the growth of the ERα-positive breast cancer cell line MCF-7 were determined by cell number counting (0–6 days) and MTT assays (4 days).